Miglustat | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Miglustat
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Miglustat

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 3 USDMF, 1 JDMF, 1 EU WC, 7 NDC API, 6 Listed Suppliers, $ API Reference Price

10 API Suppliers
3 USDMF
1 JDMF
1 EU WC
7 NDC API
6 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

21 Drugs in Development

21 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

23 FDF Dossiers, 5 FDA Orange Book, 13 Europe, 2 Canada, 1 South Africa, 2 Listed Dossiers

23 FDF Dossiers
5 FDA Orange Book
13 Europe
2 Canada
1 South Africa
2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

7 DKSH, 1 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 1 Gangwal Healthcare, 4 ACG Worldwide, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 DFE Pharma, 1 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 3 Lonza Capsugel, 5 Microlex e.U, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 4 Roquette, 1 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Sigachi Industries, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

7 DKSH
1 Faran Shimi Pharmaceutical
3 Boai NKY Pharmaceuticals Ltd
1 Gangwal Healthcare
4 ACG Worldwide
2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 DFE Pharma
1 Gangwal Chemicals
1 Ingredion Pharma Solutions
3 Lonza Capsugel
5 Microlex e.U
1 Pharmatrans-Sanaq
1 Pluviaendo
2 Prachin Chemical
1 Qualicaps
4 Roquette
1 Seppic
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shanghai Welltone Material Technology Co., Ltd
1 Sigachi Industries
1 Ulanqab Kema New Material
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

12 Fillers, Diluents & Binders, 10 Lubricants & Glidants, 9 Disintegrants & Superdisintegrants, 8 Empty Capsules, 6 Coating Systems & Additives, 6 Thickeners and Stabilizers, 3 Coloring Agents, 2 Film Formers & Plasticizers, 2 Co-Processed Excipients, 1 Granulation, 1 Taste Masking, 1 API Stability Enhancers, 1 Emulsifying Agents, 1 Solubilizers

12 Fillers, Diluents & Binders
10 Lubricants & Glidants
9 Disintegrants & Superdisintegrants
8 Empty Capsules
6 Coating Systems & Additives
6 Thickeners and Stabilizers
3 Coloring Agents
2 Film Formers & Plasticizers
2 Co-Processed Excipients
1 Granulation
1 Taste Masking
1 API Stability Enhancers
1 Emulsifying Agents
1 Solubilizers

DIGITAL CONTENT

22 NEWS #PharmaBuzz

22 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 10 Finished Drug Prices, 1 Annual Reports

2 US Medicaid Prescriptions
10 Finished Drug Prices
1 Annual Reports

MARKET PLACE

7 APIs, 4 FDF Dossiers

7 APIs
4 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 US Patents, 1 US Exclusivities, 1 Health Canada Patents

7 US Patents
1 US Exclusivities
1 Health Canada Patents

$ API Ref.Price (USD/KG) : 27,335 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Janssen Inc.

filter Patent Reset all filters

1 All

01 12368814

filter Product Reset all filters

1 All

01 1Miglustat

filter Dosage Reset all filters

1 All

01 1Capsules

filter Exp Date Reset all filters

1 All

01 12020-04-20

Product Main Page

01

Janssen Inc.

Miglustat

PharmScience R&D

Not Confirmed

Janssen Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-04-20

Date Granted : 2010-09-07

Brand Name : ZAVESCA

Patent Number : 2368814

Filing Date : 2000-04-20

Strength per Unit : 100 mg

Dosage Form : Capsules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-04-20

Date Granted : 2010-09-07

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!